Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-09-25
2007-09-25
Bernhardt, Emily (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S344000, C544S345000, C544S277000
Reexamination Certificate
active
10510066
ABSTRACT:
The present invention is directed to compounds comprising a ring-fused quinoxalinyl moiety which inhibit the activity of Akt, a serine/threonine protein kinase. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for treating cancer comprising administration of the compounds of the invention
REFERENCES:
patent: 6329375 (2001-12-01), Tang et al.
patent: 2002/0127214 (2002-09-01), Hemmings
patent: 97/22360 (1997-06-01), None
patent: WO 99/07701 (1999-02-01), None
patent: 99/42461 (1999-06-01), None
patent: 01/34607 (2001-05-01), None
patent: 01/91754 (2001-12-01), None
patent: WO 02/094796 (2002-11-01), None
patent: WO 03/084473 (2003-10-01), None
Nakatani et al. J.Biol.Chem. vol. 274, p. 21528-21532 (1999).
Bellacosa et al. Intl.J.Cancer, vol. 64, p. 280-285 (1995).
Hanada et al. Biochimica et Biophysica Acta, vol. 1697, p. 3-16 (2004).
Lindsley Craig W.
Zhao Zhijian
Bernhardt Emily
Leff Matthew A.
Merck & Co. , Inc.
LandOfFree
Inhibitors of Akt activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of Akt activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of Akt activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3764164